Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05257551 |
Recruitment Status :
Recruiting
First Posted : February 25, 2022
Last Update Posted : April 3, 2024
|
Sponsor:
Tempus AI
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Tempus AI
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | March 2026 |
Estimated Study Completion Date : | March 2026 |
Publications:
Howlader, Nnam, A. M. Noone, Me Krapcho, D. Miller, A. Brest, M. Yu, J. Ruhl, et al. 2020."SEER Cancer Statistics Review, 1975--2017." National Cancer Institute.